Comparison of the BlockbusterTM and Air-Q® Supraglottic Airway Devices as a Conduit to Blind Endotracheal Intubation in Paediatric Patients: A Randomised Control Trial
PDF
Cite
Share
Request
Original Article
VOLUME: 54 ISSUE: 4
P: 299 - 306
August 2026

Comparison of the BlockbusterTM and Air-Q® Supraglottic Airway Devices as a Conduit to Blind Endotracheal Intubation in Paediatric Patients: A Randomised Control Trial

Turk J Anaesthesiol Reanim 2026;54(4):299-306
1. All India Institute of Medical Sciences Patna, Department of Anaesthesiology, Patna, India
2. India Gandhi Institute of Medical Sciences Patna, Department of Paediatric Surgery, Patna, India
No information available.
No information available
Received Date: 28.06.2025
Accepted Date: 05.07.2026
Online Date: 28.08.2026
Publish Date: 28.08.2026
PDF
Cite
Share
Request

Abstract

Objective

Only two devices [air-Q® intubating laryngeal airway (ILA) and AmbuAura-i] have been studied previously for blind endotracheal intubation (ETI) in paediatric patients. The aim of the study was to compare the success rate of blind ETI through BlockbusterTM laryngeal mask (LM) and air-Q® ILA in paediatric patients.

Methods

Eighty patients with the American Society of Anesthesiologists’ physical status I and II, aged between six months and 10 years, were enrolled in this randomised controlled trial. The patients were intubated through either of the supraglottic airway devices (SADs) by visualised, blind intubation. The primary outcome was the first- attempt success rate of ETI. Secondary outcomes were the overall success rate of ETI, the oropharyngeal leak pressure, the fiberoptic glottic view, the time to intubation, and the complication rate.

Results

BlockbusterTM LM was having significantly higher first attempt success rate without any manipulation as compared to air-Q® ILA (55% vs. 32.5%; P value =0.042). Overall success rate was also significantly higher in BlockbusterTM LM (77.5% vs. 55%; P value =0.03). In subgroup analyses, BlockbusterTM LM demonstrated significantly higher first-attempt and overall intubation success rates in children aged 6 months to 5 years, while success rates were comparable between devices among children older than 5 years.

Conclusion

BlockbusterTM LM, having more than 50% success rate of first-attempt blind intubation through SAD, can be a helpful device in crises during airway management of children and, thus, an ideal SAD for difficult airway carts.

Keywords:
Airway management, fiberoptic, intubation, paediatric anaesthesia, supraglottic device

Main Points

• Only two devices [air-Q® intubating laryngeal airway (ILA) and AmbuAura-i] have been studied for blind endotracheal intubation through supraglottic airway devices (SADs) in paediatric patients; air-Q® ILA has been found to have a better first attempt success rate among the two, ranging from 15-64%.

• BlockbusterTM laryngeal mask (LM) is a newer SAD with a significantly better first attempt and overall success rate of blind intubation in children than air-Q® ILA.

• BlockbusterTM LM having significantly higher oropharyngeal leak pressures than air-Q® ILA, is better suited as a ventilatory device in surgeries requiring higher airway pressures.

Introduction

Airway management in children can sometimes be particularly challenging and may require essential skills. The reported incidence of difficult intubation is 0.24-4.7% and 0.07-0.7% in infants and older children, respectively.1 As attempts at laryngoscopy increase in children, it is associated with high failure rates and incidence of severe respiratory complications responsible for perioperative morbidity and mortality.2 According to the paediatric perioperative cardiac arrest registry, 27% of all cardiac arrests occur due to respiratory-related events.3

The use of supraglottic airway devices (SADs) as a conduit to endotracheal intubation (ETI) (with or without flexible bronchoscopic guidance) is an accepted technique that has gained recognition on the emergency pathway of the American Society of Anesthesiologists (ASA) paediatric difficult airway algorithm.4 as well as in the Difficult Airway Society (DAS) guidelines.5

SADs can be used as a conduit for tracheal intubation, either with a fiberoptic bronchoscope (FOB) or blindly (without flexible bronchoscopic guidance). The success rate of ETI through these SADs ranges widely from 15% to 97%, depending on the type of SADs used, characteristics of patients, and operator-acquired skills.6-8

Based on various studies conducted in adults, the Fastrach laryngeal mask (LM) Airway or intubating LMA is recommended as a prototype standard reference device for blind ETI, owing to its great success9 but its paediatric size is not available.10 Only two devices [air-Q® intubating laryngeal airway (ILA) and AmbuAura-i] have been studied for blind ETI through SADs in paediatric patients; air-Q® ILA has been found to have a better first-attempt success rate between the two, ranging from 15-63%.11-16

BlockbusterTM LM has a success rate of 90% for blind ETI in adults.8 Limited paediatric data are available, with recent evidence evaluating BlockbusterTM LM primarily as a conduit for fiberoptic-guided intubation in children.17, 18 However, its performance for blind intubation, which may be required in emergency or resource-limited settings, remains inadequately studied. The proposed study aims to answer the research question that which SAD (BlockbusterTM LM or air-Q® ILA) has a higher first-attempt success rate for blind ETI in paediatric patients. The results can be further extrapolated to the use of SAD when FOBs are limited.

The study’s primary outcome was the first-attempt success rate of ETI. Secondary outcomes were the overall success rate of ETI, the number of attempts required for successful placement of SAD, the oropharyngeal leak pressure (OLP), the glottic view through a FOB, the time needed for successful intubation, and the incidence of peri- and post-procedural complications.

Methods

This single-center, parallel-group, randomized controlled trial received ethical approval from the All India Institute of Medical Sciences, Patna ethics committee (approval: AIIMS/Pat/IEC/PGTh, date: 25.03.2021). It was then conducted in a tertiary healthcare setting and registered in the Clinical Trials Registry of India (CTRI/ 2021/ 03/ 032076). Recruitment was performed between March and October 2021. Written informed consent was obtained from the patient’s legal guardians, and oral assent was taken from the child wherever applicable. This manuscript adheres to the applicable CONSORT guidelines.

Paediatric patients with ASA-physical status (ASA-PS) I and II aged between 6 months and 10 years, weighing 5 to 30 kg, and scheduled for elective surgery under general anaesthesia were recruited for the study. Patients with an anticipated difficult airway, significant cardiopulmonary disease, obesity, airway surgery, or expected postoperative admission to the intensive care unit were excluded from the study. 104 patients were assessed for eligibility, and 80 were randomised into two equal groups.

A block randomisation sequence list was created online (https://www.sealedenvelope.com) by an individual not involved in the study. The opaque envelope method of concealment was used in the study. After enrollment, envelopes were opened by an independent person on the morning of surgery, and patients were allocated to two groups according to the sequence number in a 1:1 ratio.

Group 1: Airway secured with air-Q® ILA

Group 2: Airway secured with BlockbusterTM LM

Each group consisted of 40 patients. All the children were kept nil by mouth according to standard guidelines. No premedication was administered to the patient.

Inhalational induction with sevoflurane was performed, followed by administration of fentanyl at 2 µg kg-1. The neuromuscular blockade was achieved with atracurium at 0.5 mg kg-1 after confirming mask ventilation. After ventilating the patient for 3 minutes, achieving a minimum alveolar concentration of 1.0-1.2, the airway was secured with an appropriately sized SAD according to the patient’s weight per the allotted group. The air-Q® ILA sizes 1, 1.5 and 2 were used for the patient weight of (<7 kg), (7-17) kg and (17-30) kg, respectively. The BlockbusterTM LM sizes of 1.5, 2, and 2.5 were used for patient weights of (5-10) kg, (10-20) kg, and (20-30) kg, respectively.

All airway interventions were performed by the investigators, who were certified and trained anaesthesiologists. The performers had experience using other SADs (more than 100) in children as part of routine practice. The performers were trained on manikins with the SADs used in the study and used them on a limited number of patients before the study.

The SADs were lubricated with a water-soluble agent and inserted using the recommended midline technique. A maximum of three SAD insertion attempts with minor airway interventionswas allowed. Successful placement of SAD was determined by achieving at least 5 ml kg-1 tidal volume, bilateral chest excursion, and a square-wave capnogram upon delivery of a positive-pressure breath, with a tidal-volume leak <10%. The OLP was measured by closing the expiratory valve of the circle system with a fresh gas flow of 3 L min-1 and noting the airway pressure at which equilibrium was reached. The pressure was not allowed to exceed 40 cm of H2O.

Volume-controlled ventilation mode was used with a target tidal volume of 8-10 mL kg-1 and a respiratory rate of 14-20 times per minute to maintain an EtCO2 between 30-40 mm of Hg. A paediatric FOB (Karl Storz, Tuttlingen, Germany) was fitted with a cuffed polyvinyl chloride endotracheal tube (ETT) of a size appropriate for the patient’s age. The ETT was taped to the FOB so that the tip of the FOB did not extend beyond the ETT (Figure 1). The breathing circuit was disconnected at the patient end, and the ETT-loaded FOB was inserted through the SAD. During the visualisation of the laryngeal structures, a fiberoptic view through the opening of the SAD was recorded by a member of the anaesthesia care team. Scoring of the fibreoptic glottic view was based on Brimacombe’s laryngeal view and was recorded as follows (Figure 2):19

1. Grade 0: failure to function of LMA where cords are not seen fibre-optically,

2. Grade 1: cords not seen, but the function of LMA is adequate,

3. Grade 2: The cords and the anterior epiglottis are visible,

4. Grade 3: cords plus posterior epiglottis are seen,

5. Grade 4: only cords are seen.

For glottic view grades 2, 3, and 4, we attempted ETI. We used a visualised blind technique for intubation, as previously described in the literature, to prevent injury to the delicate laryngeal structures of the child.11, 20, 21 To reduce performer bias, the performer did not view the fiberoptic screen during intubation. The FOB did not guide the insertion of the ETT but, instead, followed its progress (Figure 1). The performer was also not allowed to use the fiberscope’s lever. An assisting anaesthesiologist communicated with the performer regarding the advancement of the ETT by using only the terms “Go,” “Slow,” “Stop,” and “Back” after the visualisation of the FOB laryngeal-view grade.

The first successful attempt at ETI was defined when ETT was advanced directly into the glottic opening and confirmed by capnography. If the ETT deviated into extraglottic structures during the procedure, corrective manoeuvres, such as mandibular lift and rotation of the ETT, were used. If the grade improved, we proceeded with ETI; if the grade did not improve, it was considered a failed attempt at blind intubation. ETI, with corrective manoeuvres, was considered a subsequent attempt at intubation. Correction manoeuvres were also applied to the grade 1 glottic view.

Patients were ventilated for 3 minutes after successful ETI, after which the SAD was removed using the removal stylet. One visualised blind intubation attempt lasting no more than 2 minutes was allowed. The intubation was recorded as a failure:

1. The correct placement of the SADs was not achieved after three attempts despite minor airway interventions.

2. The tracheal tube was dislodged during SAD removal.

3. Deviation of ETT away from the laryngeal inlet despite using correction manoeuvres.

The various endpoints were defined as follows:

1. Time for the successful placement of SAD: From discontinuation of facemask ventilation to the rise of 1st square wave of the capnographic waveform.

2. Time for the successful insertion of the ETT: From discontinuation of the breathing circuit after SADs placement to 1st square wave of the capnographic waveform.

3. Time for the successful removal of SAD: From disconnection of the breathing circuit after successful ETI till reconnection of the breathing circuit to the ETT.

All outcome variables were noted in the data collection proforma by a member of the anaesthesia care team. Adverse events such as aspiration or regurgitation, hypoxia, bronchospasm, laryngospasm, desaturation (SpO2<92%), coughing, blood-staining on the SAD, and trauma to teeth, tongue, or lips were recorded. Patients older than three years were observed for sore throat, postoperative nausea and vomiting, hoarseness, and dysphagia in the post-anaesthesia care unit. A follow-up twenty-four hours after surgery and interviews about side effects were conducted with the child and the parents.

Statistical Analysis

The authors conducted a pilot study on 12 patients in each group, the success rates of BlockbusterTM LM and air-Q® being 66% and 33%, respectively. The calculated sample size was 35 in each arm, considering a power of 80%, a 95% confidence interval, and a two-tailed alpha of 0.05. We planned to recruit 40 patients in each arm, allowing for dropouts.

All data were recorded on a standardised data collection sheet, and were analysed using the statistical software SPSS 26.0 (SPSS, Chicago, IL, USA). The normality of the data was tested using visual inspection of the Q-Q plot and the Shapiro-Wilk test. Descriptive parametric data were expressed as mean ± standard deviation and non-parametric data as median and interquartile range. Parametric continuous variables were compared using the independent-samples t-test. Non-parametric continuous variables were compared using the independent-samples Mann-Whitney U test. Categorical and ordinal data were compared using the chi-square test or Fisher’s exact test. A post-hoc, age-based subgroup analysis was performed for outcomes including the first-attempt and overall success rates of ETI. A P value of < 0.05 was considered statistically significant.

Results

Of the 104 patients assessed for eligibility, 18 did not meet the inclusion criteria, and consent for participation in the study could not be obtained from the guardians of 6 patients. The remaining 80 patients were randomised to two study groups and underwent interventions per protocol, as represented in the CONSORT flow diagram (Figure 3).

Groups 1 and 2 each had 40 patients at the final analysis. There were no statistically significant differences between the groups regarding demographic data (age, gender, height, weight, body mass index, ASA-PS) (Table 1).

Group 2 had a significantly higher first-attempt success rate than Group 1 (55% vs. 32.5%; P value =0.042) (Table 2). The overall success rate of ETI was significantly higher in Group 2 than in Group 1 (77.5% vs. 55%; P value =0.03) (Table 2).

In the subgroup of children aged 6 months to 5 years (n = 57), the first-attempt success rate for ETI was significantly higher in Group 2 than in Group 1 (53.8% vs. 25.8%; P=0.030). The overall success rate was also significantly higher in Group 2 (73% vs. 45.2%; P=0.033). In children aged >5-10 years (n = 23), no statistically significant difference was observed between the two devices for either first-attempt success (57.1% vs. 55.5%; P=0.94) or for overall success rate (85.7% vs. 77.7%; P=0.624) (Table 3).

SAD was placed in a single attempt in all patients except one in Group 2, in whom placement was unsuccessful despite the maximum allowable attempts (three, per protocol). Failure to place the SAD was counted as an unsuccessful intubation attempt.

The OLP (in cm of H2O) was significantly higher in Group 2 than the OLP of Group 1 (25.74±7.05 vs. 15.2±5.58; value =0.001) (Table 2).

FOB visualisation of vocal cords (Grades 2/3/4) was observed in 62.5% of Group 1 patients versus 84.6% of Group 2 patients (P value =0.026). This variation was statistically significant (Table 2).

The time (in seconds) required for successful insertion of ETT was significantly less in Group 2 [60 (53-60)] than in Group 1 [50 (39-60)] (P value =0.019) (Table 2).

The time required for SAD insertion, removal, and tidal volume leak was not statistically significant (Table 2).

The SAD sizes used in both groups are presented in Table 2. The statistical analysis of the sizes cannot be interpreted because the weight corresponding to specific sizes differed between the two groups , in accordance with the manufacturer’s recommendations.

The number of patients successfully intubated after using corrective manoeuvres was 8 in Group 1 and 9 in Group 2 (Table 2).

There was no significant difference in the incidence of complications between the two groups (Table 4).

Discussion

In the present study, both the first attempt and overall success rate with BlockbusterTM LM were significantly better compared to air-Q® ILA (55% and 77.5% vs. 32.5% and 55%). The age-based subgroup analysis provides important insights into how paediatric airway development influences intubation success. Among children aged 6 months to 5 years, BlockbusterTM LM demonstrated significantly higher first-attempt and overall success rates than air-Q® ILA. This finding is clinically relevant because younger children have a relatively larger, floppier epiglottis, a higher, more anterior larynx, and reduced alignment of the SAD with the glottic opening. These anatomical features may favour devices with a guided tube-directing mechanism, such as the BlockbusterTM LM. In contrast, children older than 5 years have airway anatomy that is more adult-like, with improved laryngeal alignment and increased epiglottic rigidity, which likely explains the comparable success rates observed between the two devices in this age group.

In a previous study in adults, BlockbusterTM LM had a first-attempt blind ETI success rate of 90%.8 The success rate of blind ETI through air-Q® ILA in paediatric patients is 15-63% in various studies.11-16 and is the highest among all the SADs that have been studied in paediatric patients. Soni et al.17 and Chauhan et al.18 evaluated BlockbusterTM LM and air-Q® ILA as conduits for fiberoptic-guided intubation in children and reported comparable intubation success rates between the devices. In contrast, the present study focuses on visualised-blind intubation which is specifically relevant to emergency, resource-limited, and crisis airway scenarios, and additionally reports OLPs and a subgroup analysis of younger children.

BlockbusterTM LM is a newer SAD with unique features like a gastric inlet port and a guidance device that allows the ETT to be directed towards the laryngeal opening at 30-degree angle. These features are expected to increase the success rate of ETI.

As defined by TM Cook, the suffix “i” should be added to those devices that enable intubation (e.g., with success >50%),22 and thus, these SADs can be helpful in situations where the use of FOBs is limited. BlockbusterTM LM, having a better success rate of blind intubation, can be a preferred device for managing crises during difficult airway management of children.

OLP is considered a good measure of airway protection, of successful SAD placement with a better seal, and of adequate positive pressure ventilation. In the present study, the OLP in BlockbusterTM LM was significantly higher than air-Q® ILA [25.9 (22-32) vs. 12 (11-20.2)]. Both SADs have an adequate OLP, with a tidal-volume leak of only 1-3%. W e suggest that both SADs can be used effectively as ventilatory devices. SADs are successfully being used as a primary ventilatory device in paediatric patients undergoing laparoscopic surgeries.23 BlockbusterTM LM, due to better OLP, can be used as an effective device for surgeries requiring higher ventilatory pressures, like laparoscopic surgeries, obese patients, and Trendelenburg position. A recent study has also shown better OLP of BlockbusterTM LM (24.72±6.81 cm H2O), similar to our findings.24

Various manoeuvres have been described to facilitate insertion and ETI via SADs, such as mandibular lift, ETT rotation, and the Chandy manoeuvre. Intubation was successful in about 20% of patients in both groups after corrective manoeuvres were applied. Manoeuvres were not helpful for any patients with Grade I glottic views. Manoeuvres were unsuccessful in 70% and 47% with air-Q® ILA and BlockbusterTM LM, respectively. No injuries or complications occurred during the attempt at corrective manoeuvres. We suggest that correction manoeuvres should be applied on subsequent attempts after encountering resistance during the advancement of the ETT or after a failed first attempt.

There is a potential chance of airway trauma and epiglottic down folding during blind attempts of ETI in children.25, 26 Therefore, to avoid trauma to the delicate paediatric airway, we used a “visualised blind intubation” technique. The number of patients with an unsuitable glottic view (grade 1) was significantly higher in the air-Q® ILA group than in the BlockbusterTM LM group (37.5 % vs. 15.4 %). In the BlockbusterTM LM group, although the optimal glottic view was achieved in 84.6% of children, the intubation success rate was lower than expected. This might be due to the smaller size of the glottic opening in children compared to adults. Moreover, the Parker Flex-Tip tracheal tube is recommended by the manufacturers of BlockbusterTM LM for blind tracheal intubation. This use of the tube might have increased the success rate further.

SAD insertion was successful in the first attempt in all patients except one with BlockbusterTM LM. Meta-analysis on the use of air-Q® ILA in paediatric patients has also shown similar results, with a 100% success rate of device insertion in most of the studies.13 BlockbusterTM LM in adult patients also had a 100% first-attempt success rate.8 SAD insertion and removal times were similar between the two groups. ETT insertion time was significantly longer with air-Q® ILA compared to BlockbusterTM LM (60 vs. 50 seconds). However, this time difference of 10 seconds is clinically insignificant in routine practice.

Complications during ETI through SADs were neither statistically nor clinically significant.

Study Limitations

Our study has limitations that should be considered when interpreting our results. First, we have not included patients younger than six months of age in our research. The infants have large, floppy epiglottises, which prevent the visualisation of the glottis. Thus, the success rate in infants may be lower than in older children. Second, we selected patients with body weights ranging from 5 kg to 30 kg; therefore, the findings might not apply to underweight or overweight patients. Third, the subgroup analysis was post hoc and not powered a priori; therefore, these findings should be interpreted cautiously. Fourth, we have used a visualised-blind method of ETI, rather than truly blind ETI, to avoid airway injury. The visualised blind technique prevented us from advancing the ETT in the event that it deviated from the correct path. The true blind technique might have resulted in inadvertent, forceful insertion, which, at the expense of causing airway trauma, might have increased the first-attempt success rate. Fifth, because our study included patients with normal airways, the results may not apply to patients with difficult airways. We suggest further research comparing SADs as intubating devices in infants.

In general, it is advisable to use fiberoptic-guided intubation through an SAD. However, in some situations, fiberoptic-guided intubation may be difficult, such as when bleeding or secretions are present. In prehospital settings or by novice physicians, blind intubation through SAD may be attempted when a definitive airway is required during an emergency. Blind ETI through SAD is also helpful during airway crises in children.

Conclusion

BlockbusterTM LM, having a 50% to 77.5% success rate of blind intubation through SAD, can be a helpful device in crises and, thus, a preferred SAD for difficult airway carts. Both air-Q® ILA and Blockbuster LM have a first-attempt SAD insertion success rate of about 100% with non-significant tidal volume leak. Therefore, both devices can be used effectively for ventilation. BlockbusterTM LM has a significantly higher OLP than air-Q® ILA; therefore, BlockbusterTM LM can be used as a better ventilatory device in surgeries requiring higher airway pressure, like laparoscopic surgeries or obese patients.

Ethics

Ethics Committee Approval: This single-center, parallel-group, randomized controlled trial received ethical approval from the All India Institute of Medical Sciences, Patna ethics committee (approval: AIIMS/Pat/IEC/PGTh, date: 25.03.2021).
Informed Consent: Written informed consent was obtained from guardians.
Authorship Contributions: Surgical and Medical Practices - A.P., A.K., C.S., N.K.; Concept - A.P., A.K., C.S.; Design - A.P., A.K.; Data Collection or Processing - A.P., A.K., C.S., N.K., A.Ku., B.K., R.K.; Analysis or Interpretation - A.P., A.K., C.S., N.K., A.Ku., B.K., R.K.; Literature Search - A.P., A.K., C.S., N.K., Writing - A.P., A.K., C.S., N.K., A.Ku., B.K., R.K.
Declaration of Interests: The authors declare no conflict of interests.
Funding: No funding was received for the study.
Prior Presentation: The abstract paper was presented at the 68th annual conference of the Indian Society of Anaesthesiologists in Ahmedabad, India on 24-28 November, 2021. The abstract was published in the January 2022 supplement of the Indian Journal of Anaesthesia.

References

1
Heinrich S, Birkholz T, Ihmsen H, Irouschek A, Ackermann A, Schmidt J. Incidence and predictors of difficult laryngoscopy in 11,219 pediatric anesthesia procedures. Paediatr Anaesth. 2012;22(8):729-736.
2
Fiadjoe JE, Nishisaki A, Jagannathan N, et al. Airway management complications in children with difficult tracheal intubation from the pediatric difficult intubation (PeDI) registry: a prospective cohort analysis. Lancet Respir Med. 2016;4(1):37-48.
3
Bhananker SM, Ramamoorthy C, Geiduschek JM, et al. Anesthesia-related cardiac arrest in children: update from the pediatric perioperative cardiac arrest registry. Anesth Analg. 2007;105(2):344-350.
4
Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway. Anesthesiology. 2022;136(1):31-81.
5
Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015;115(6):827-848.
6
Bakker EJ, Valkenburg M, Galvin EM. Pilot study of the air-Q intubating laryngeal airway in clinical use. Anaesth Intensive Care. 2010;38(2):346-348.
7
Erlacher W, Tiefenbrunner H, Kästenbauer T, Schwarz S, Fitzgerald RD. CobraPLUS and Cookgas air-Q versus Fastrach for blind endotracheal intubation: a randomised controlled trial. Eur J Anaesthesiol. 2011;28(3):181-186.
8
Endigeri A, Ganeshnavar A, Varaprasad B, Shivanand YH, Ayyangouda B. Comparison of success rate of BlockBuster ® versus Fastrach ® LMA as conduit for blind endotracheal intubation: a prospective randomised trial. Indian J Anaesth. 2019;63(12):988-994.
9
Timmermann A. Supraglottic airways in difficult airway management: successes, failures, use and misuse. Anaesthesia. 2011;66(Suppl 2):45-56.
10
Gerstein NS, Braude DA, Hung O, Sanders JC, Murphy MF. the fastrach intubating laryngeal mask airway: an overview and update. Can J Anaesth. 2010;57(6):588-601.
11
Kleine-Brueggeney M, Nicolet A, Nabecker S, et al. Blind intubation of anaesthetised children with supraglottic airway devices AmbuAura-i and air-Q cannot be recommended: a randomised controlled trial. Eur J Anaesthesiol. 2015;32(9):631-639.
12
El-Emam EM, El Motlb EAA. Blind tracheal intubation through the air-Q intubating laryngeal airway in pediatric patients: reevaluation - a randomized controlled trial. Anesth Essays Res. 2019;13(2):269-273.
13
Ahn EJ, Choi GJ, Kang H, et al. Comparative efficacy of the air-Q intubating laryngeal airway during general anesthesia in pediatric patients: a systematic review and meta-analysis. Biomed Res Int. 2016;2016:6406391.
14
Jagannathan N, Kho MF, Kozlowski RJ, Sohn LE, Siddiqui A, Wong DT. Retrospective audit of the air-Q intubating laryngeal airway as a conduit for tracheal intubation in pediatric patients with a difficult airway. Paediatr Anaesth. 2011;21(4):422-427.
15
Pandey RK, Subramanium RK, Darlong V, et al. Evaluation of glottic view through air-Q Intubating Laryngeal Airway in the supine and lateral position and assessing it as a conduit for blind endotracheal intubation in children in the supine position. Paediatr Anaesth. 2015;25(12):1241-1247.
16
Burbano Z, Andrés M, Rivera G, et al. Blind tracheal intubation with air-Q supraglottic device: prospective case series in pediatrics. Colombian Journal of Anesthesiology. 2018;46(2S):21-25.
17
Soni L, Kumar KR, Sinha R, Ayub A, Patel N. Comparison of BlockBuster laryngeal mask with Air-Q intubating laryngeal airway as a conduit for fiber-optic guided intubation in children: a prospective randomized controlled study. Paediatr Anaesth. 2024;34(7):671-677.
18
Chauhan K, Kerai S, Saxena KN, Gupta L, Prathap TH, Wadhawan S. Comparison of BlockBuster ® laryngeal mask airway and air-Q ® intubating laryngeal airway as a conduit for fibreoptic bronchoscopy-guided tracheal intubation in paediatric patients: a randomised comparative study. Indian J Anaesth. 2025;69(7):687-692.
19
Brimacombe J, Berry A. A proposed fiber-optic scoring system to standardize the assessment of laryngeal mask airway position. Anesth Analg. 1993;76(2):457.
20
Zuercher M, Casso G, Krugel V, Potié A, Barry MP, Schoettker P. Tracheal intubation using intubating laryngeal tube iLTS-D™ and LMA Fastrach™ in 99 adult patients: a prospective multicentric randomised non-inferiority study. J Clin Anesth. 2022;78:110671.
21
Theiler L, Kleine-Brueggeney M, Urwyler N, Graf T, Luyet C, Greif R. Randomized clinical trial of the i-gel™ and Magill tracheal tube or single-use ILMA™ and ILMA™ tracheal tube for blind intubation in anaesthetized patients with a predicted difficult airway. Br J Anaesth. 2011;107(2):243-250.
22
Cook TM. Third generation supraglottic airway devices: an undefined concept and misused term. Time for an updated classification of supraglottic airway devices. Br J Anaesth. 2015;115(4):633-634.
23
Kumar A, Sinha C, Kumar N, et al. Comparison of the oropharyngeal leak pressure between three second generation supraglottic airway devices during laparoscopic surgery in pediatric patients. Paediatr Anaesth. 2022;32(7):843-850.
24
Kumar KR, Soni L, Sinha R, et al. Comparison of ambu auragain and blockbuster laryngeal mask for controlled ventilation in children undergoing minor surgical procedures under general anesthesia: a prospective randomized controlled study. Paediatr Anaesth. 2023;33(6):474-480.
25
Auden SM, Lerner GM. Blind intubation via the laryngeal mask: a word of caution. Paediatr Anaesth. 2000;10(4):452.
26
Inagawa G, Okuda K, Miwa T, Hiroki K. Higher airway seal does not imply adequate positioning of laryngeal mask airways in paediatric patients. Paediatr Anaesth. 2002;12(4):322-326.